† The PCR process is covered by patents owned by Roche Molecular Systems, Inc.,
and F. Hoffman-La Roche, Ltd.
* All trademarks are property of their respective owners.
Beckman Coulter and the stylized logo are registered trademarks of Beckman Coulter, Inc.
Biologics Testing
Beckman Coulter Genomics offers a range of services aimed to evaluate the stability, purity, and safety of biological products. These services are compliant with GLP/cGMP regulations to support pre-clinical, clinical, and post market needs in different market segments.
Service Offerings
- Residual DNA Testing
- Microbial Detection and Differentiation
- Diagnostic Kit and Device Validation
Technology Platforms
ABI 7900HT
Quantitative real-time PCR† using the ABI* 7900HT system is ideal for detecting and quantitating nucleic acid sequences to support the drug discovery process. Using the ABI 7900HT System, Beckman Coulter Genomics delivers:
- High throughput and capacity
- TaqMan* Inventoried or Made to Order assays
- Custom assay design, development and validation
- Research-grade or regulatory-compliant services
